Trademark: 97020081
Status Date
Friday, March 8, 2024
Filing Date
Thursday, September 9, 2021
Published for Opposition
Tuesday, July 19, 2022
5 Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, namely, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, Light Chain Amyloidosis and LECT2 Amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use
The mark consists of a spiral design made of dots of various sizes.
Color is not claimed as a feature of the mark.
Mar 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 8, 2024
Sou Extension 3 Granted
Mar 8, 2024
Sou Extension 3 Filed
Mar 8, 2024
Sou Teas Extension Received
Aug 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2023
Sou Extension 2 Granted
Aug 17, 2023
Sou Extension 2 Filed
Aug 17, 2023
Sou Teas Extension Received
Mar 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2023
Sou Extension 1 Granted
Mar 1, 2023
Sou Extension 1 Filed
Mar 1, 2023
Sou Teas Extension Received
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 13, 2022
Approved For Pub - Principal Register
Jun 13, 2022
Assigned To Examiner
Oct 20, 2021
Notice Of Design Search Code E-Mailed
Oct 19, 2021
New Application Office Supplied Data Entered
Sep 13, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
